On the public citation graph
Landmark Alzheimer’s drug approval confounds research community
0 signed · 141 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4702812openalex-extracted
HSPA8 and 3,4,5-Tricaffeoylquinic Acid May Be Essential Hub Genes and Active Components for the Treatment of Alzheimer's Disease with Erigeron Breviscapus (Vant.) Hand-Mazz by Regulating Ferroptosis: A Study Based on WGCNA, Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations
inferred← citeshttps://doi.org/10.2139/ssrn.4755485openalex-extracted
A Pharmacological Toolkit for Human Microglia Identifies Topoisomerase I Inhibitors as Immunomodulators for Alzheimer's Disease
inferred← citeshttps://doi.org/10.1002/alz.12610openalex-snapshot
Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis
inferred← citeshttps://doi.org/10.1002/bkcs.12372openalex-snapshot
Redox Properties of Small Molecules Essential for Multiple Reactivities with Pathological Factors in Alzheimer's Disease
inferred← citeshttps://doi.org/10.1002/gps.5978openalex-snapshot
Could routine vaccinations prevent dementia?
inferred← citeshttps://doi.org/10.1002/med.22033openalex-snapshot
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
inferred← citeshttps://doi.org/10.1007/7854_2024_524openalex-snapshot
Involvement of Complement in Alzheimer’s Disease: From Genetics Through Pathology to Therapeutic Strategies
inferred← citeshttps://doi.org/10.1007/978-1-0716-3311-3_3openalex-snapshot
Recent Advances in Computational Modeling of BACE1 Inhibitors as Anti-Alzheimer Agents
inferred← citeshttps://doi.org/10.1007/978-3-030-99838-7_4openalex-snapshot
New Horizons in Studying the Cellular Mechanisms of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-31570-1_19openalex-snapshot
Driving Forces of Alzheimer’s Research Directions
inferred← citeshttps://doi.org/10.1007/978-3-662-66303-5_28openalex-snapshot
Neurodegenerative Erkrankungen
inferred← citeshttps://doi.org/10.1007/978-3-662-72210-7_19openalex-snapshot
Treibende Kräfte bei der Ausrichtung der Alzheimer-Forschung
inferred← citeshttps://doi.org/10.1007/978-981-95-2070-1_9openalex-snapshot
Machine Learning Applications for Brain Disorders: Towards Inclusivity and Equity
inferred← citeshttps://doi.org/10.1007/s00044-024-03261-9openalex-snapshot
Amyloid-independent pathogenesis for Alzheimer’s disease: implications for drug design
inferred← citeshttps://doi.org/10.1007/s00210-025-04446-8openalex-snapshot
Alzheimer’s disease: unraveling role of xanthone derivatives and nanocarriers
inferred← citeshttps://doi.org/10.1007/s00281-022-00944-6openalex-snapshot
The aging immune system in Alzheimer’s and Parkinson’s diseases
inferred← citeshttps://doi.org/10.1007/s11229-024-04677-xopenalex-snapshot
The reliability of evidential pluralism in drug regulation
inferred← citeshttps://doi.org/10.1007/s11357-024-01305-xopenalex-snapshot
Electrical brain networks before and after transcranial pulsed shockwave stimulation in Alzheimer’s patients
inferred← citeshttps://doi.org/10.1007/s11948-022-00422-0openalex-snapshot
A Review of Scientific Ethics Issues Associated with the Recently Approved Drugs for Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/s12152-023-09522-5openalex-snapshot
Mild Cognitive Impairment in Relation to Alzheimer’s Disease: An Investigation of Principles, Classifications, Ethics, and Problems
inferred← citeshttps://doi.org/10.1007/s12200-023-00080-5openalex-snapshot
Mechanisms of phototherapy of Alzheimer’s disease during sleep and wakefulness: the role of the meningeal lymphatics
inferred← citeshttps://doi.org/10.1007/s12603-021-1654-yopenalex-snapshot
Management of Cognitive Dysfunction
inferred← citeshttps://doi.org/10.1007/s13194-023-00537-6openalex-snapshot
Socially responsible science: Exploring the complexities
inferred← citeshttps://doi.org/10.1007/s13205-024-03925-8openalex-snapshot
Natural flavonoids as potential therapeutics in the management of Alzheimer’s disease: a review
inferred← citeshttps://doi.org/10.1007/s13311-021-01152-0openalex-snapshot
Genomics and Functional Genomics of Alzheimer's Disease
inferred← citeshttps://doi.org/10.1007/s13659-022-00354-zopenalex-snapshot
Therapeutic roles of plants for 15 hypothesised causal bases of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s40120-022-00423-yopenalex-snapshot
Treatment Preference for Alzheimer’s Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors
inferred← citeshttps://doi.org/10.1016/b978-0-443-19081-0.00014-7openalex-snapshot
Role of anandamide in Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/b978-0-443-22300-6.00055-3openalex-snapshot
The path towards precision medicine: Next generation biotherapeutics and delivery strategies across the blood–brain barrier for the treatment of neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114517openalex-snapshot
Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound
inferred← citeshttps://doi.org/10.1016/j.celrep.2026.118031openalex-snapshot
Topoisomerase I inhibition yields a CD74high/MHChigh human microglial subtype with enhanced Aβ uptake
inferred← citeshttps://doi.org/10.1016/j.conb.2026.103234openalex-snapshot
Gut–brain axis in Alzheimer’s disease: neural and immune circuits linking peripheral dysbiosis to neurodegeneration
inferred← citeshttps://doi.org/10.1016/j.healthpol.2023.104736openalex-snapshot
A critical analysis of national dementia care guidances
inferred← citeshttps://doi.org/10.1016/j.imr.2023.100946openalex-snapshot
Anti-oxidative-initiated cognitive impairment amelioration in Alzheimer's disease model rats through preventive transcutaneous electrical acupoint stimulation
inferred← citeshttps://doi.org/10.1016/j.it.2021.09.011openalex-snapshot
The meningeal lymphatics: regulators of Aβ immunotherapy?
inferred← citeshttps://doi.org/10.1016/j.jneumeth.2024.110209openalex-snapshot
A Systematic Online Living Evidence Summary of experimental Alzheimer’s disease research
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119824openalex-snapshot
Functional effects of berberine in modulating mitochondrial dysfunction and inflammatory response in the respective amyloidogenic cells and activated microglial cells – In vitro models simulating Alzheimer's disease pathology
inferred← citeshttps://doi.org/10.1016/j.molstruc.2024.138698openalex-snapshot
Integrated bioinformatics, network pharmacology, molecular docking, and molecular dynamics simulation to explore the potential pharmacological mechanism of Erigeron breviscapus (Vant.) Hand-Mazz regulating ferroptosis for the treatment of Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.neuint.2022.105401openalex-snapshot
Insights for Alzheimer's disease pharmacotherapy and current clinical trials
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2023.08.006openalex-snapshot
Gamma connectivity predicts response to intermittent theta burst stimulation in Alzheimer’s disease: a randomized controlled trial
inferred← citeshttps://doi.org/10.1016/j.neurol.2022.03.001openalex-snapshot
AD and its comorbidities: An obstacle to develop a clinically efficient treatment?
inferred← citeshttps://doi.org/10.1016/j.patter.2021.100433openalex-snapshot
A hybrid approach unveils drug repurposing candidates targeting an Alzheimer pathophysiology mechanism
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2021.108022openalex-snapshot
Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
inferred← citeshttps://doi.org/10.1016/j.pneurobio.2024.102585openalex-snapshot
Signal peptide peptidase-like 2b modulates the amyloidogenic pathway and exhibits an Aβ-dependent expression in Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.tips.2022.02.006openalex-snapshot
Targeting complement in neurodegeneration: challenges, risks, and strategies
inferred← citeshttps://doi.org/10.1016/j.tma.2023.06.004openalex-snapshot
Recent developments in the role of DNA damage response and understanding its implications for new therapeutic approaches in Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.yfrne.2022.100986openalex-snapshot
Role of melatonin in Alzheimer’s disease: From preclinical studies to novel melatonin-based therapies
inferred← citeshttps://doi.org/10.1016/s0140-6736(25)01389-3openalex-snapshot
Alzheimer's disease outlook: controversies and future directions
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c00733openalex-snapshot
Nonlipogenic ABCA1 Inducers (NLAI) for Alzheimer’s Disease Validated in a Mouse Model Expressing Human APOE3/APOE4
inferred← citeshttps://doi.org/10.1021/acschemneuro.3c00393openalex-snapshot
Pathogenesis of Alzheimer’s Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential
inferred← citeshttps://doi.org/10.1021/acsomega.1c06571openalex-snapshot
Memantine-Derived Schiff Bases as Transdermal Prodrug Candidates
inferred← citeshttps://doi.org/10.1021/jacs.1c08626openalex-snapshot
One-Carbon Insertion and Polarity Inversion Enabled a Pyrrole Strategy to the Total Syntheses of Pyridine-Containing Lycopodium Alkaloids: Complanadine A and Lycodine
inferred← citeshttps://doi.org/10.1038/s41380-022-01685-6openalex-snapshot
Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78–94
inferred← citeshttps://doi.org/10.1038/s41582-021-00557-xopenalex-snapshot
Can we learn lessons from the FDA’s approval of aducanumab?
inferred← citeshttps://doi.org/10.1038/s41598-022-11242-4openalex-snapshot
Nonlocal models in the analysis of brain neurodegenerative protein dynamics with application to Alzheimer’s disease
inferred← citeshttps://doi.org/10.1038/s43856-024-00682-wopenalex-snapshot
Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
inferred← citeshttps://doi.org/10.1038/s44400-026-00124-5openalex-snapshot
Stratifying Alzheimer’s disease by patient-specific genetic signatures reveals cognition-linked and cross-disease heterogeneity
inferred← citeshttps://doi.org/10.1039/d2cc06850hopenalex-snapshot
Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease
inferred← citeshttps://doi.org/10.1080/10408363.2023.2187342openalex-snapshot
Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer’s disease pathogenesis
inferred← citeshttps://doi.org/10.1080/14712598.2023.2178297openalex-snapshot
Belimumab for the treatment of pediatric patients with lupus nephritis
inferred← citeshttps://doi.org/10.1080/14756366.2022.2117912openalex-snapshot
A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE)
inferred← citeshttps://doi.org/10.1093/9780198995296.003.0006openalex-snapshot
Current treatments for dementias
inferred← citeshttps://doi.org/10.1093/braincomms/fcab217openalex-snapshot
Alzheimer’s research—breakthrough or breakdown?
inferred← citeshttps://doi.org/10.1093/genetics/iyab185openalex-snapshot
Unraveling the Gordian knot: genetics and the troubled road to effective therapeutics for Alzheimer’s disease
inferred← citeshttps://doi.org/10.1097/01.nurse.0000820024.83629.eeopenalex-snapshot
Palliative care for patients with advanced dementia
inferred← citeshttps://doi.org/10.1101/2021.09.14.21263565openalex-snapshot
An Integrated Molecular Atlas of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1101/2022.03.28.485913openalex-snapshot
A unified in vitro to in vivo fluorescence lifetime screening platform yields amyloid β aggregation inhibitors
inferred← citeshttps://doi.org/10.1101/2022.04.11.487937openalex-snapshot
A Rapid in vivo Pipeline to Identify Small Molecule Inhibitors of Amyloid Aggregation
inferred← citeshttps://doi.org/10.1101/2022.10.24.513473openalex-snapshot
Signal Peptide Peptidase-Like 2b affects APP cleavage and exhibits a biphasic Aβ-mediated expression in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1101/2023.06.13.23291049openalex-snapshot
Therapeutic potential of a modified Mediterranean ketogenic diet in reversing the peripheral lipid signature of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1101/2023.09.12.557499openalex-snapshot
Heteroscedastic Personalized Regression Unveils Genetic Basis of Alzheimer’s Disease Stratified by Cognitive Level
inferred← citeshttps://doi.org/10.1101/2024.02.06.579103openalex-snapshot
A pharmacological toolkit for human microglia identifies Topoisomerase I inhibitors as immunomodulators for Alzheimer’s disease
inferred← citeshttps://doi.org/10.1126/science.abl7597openalex-snapshot
Toward a holistic model of Alzheimer’s How Not to Study a Disease: The Story of Alzheimer’s Karl Herrup MIT Press, 2021. 272 pp.
inferred← citeshttps://doi.org/10.1136/bmj.n1682openalex-snapshot
Aducanumab for Alzheimer’s disease?
inferred← citeshttps://doi.org/10.1136/bmjebm-2022-111914openalex-snapshot
FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps
inferred← citeshttps://doi.org/10.1155/2022/9343514openalex-snapshot
Aducanumab Therapy to Treat Alzheimer’s Disease: A Narrative Review
inferred← citeshttps://doi.org/10.1177/0976500x251365078openalex-snapshot
Diabetes Mellitus-related Pathogeny: A Precipitating Factor for Alzheimer’s Disease—An Insight on Repurposing Diabetes Pharmacological Treatments in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1177/13872877241289549openalex-snapshot
Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review
inferred← citeshttps://doi.org/10.1186/s13024-021-00474-zopenalex-snapshot
Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
inferred← citeshttps://doi.org/10.1186/s13024-022-00524-0openalex-snapshot
Solving neurodegeneration: common mechanisms and strategies for new treatments
inferred← citeshttps://doi.org/10.1186/s13195-024-01413-yopenalex-snapshot
Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0258692openalex-snapshot
Tau fibril with membrane lipids: Insight from computational modeling and simulations
inferred← citeshttps://doi.org/10.15252/emmm.202114781openalex-snapshot
Aducanumab: a new phase in therapeutic development for Alzheimer’s disease?
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2589038/v1openalex-snapshot
Blocking the FAM19A5-LRRC4B complex enhances neurite growth and synapse assembly.
inferred← citeshttps://doi.org/10.2147/cia.s325026openalex-snapshot
Role of Aducanumab in the Treatment of Alzheimer’s Disease: Challenges and Opportunities
inferred← citeshttps://doi.org/10.2174/0109298673264076230921065945openalex-snapshot
Recent Advancements in the Treatment of Alzheimer’s Disease: A Multitarget-directed Ligand Approach
inferred← citeshttps://doi.org/10.2174/0115734080296802240528073027openalex-snapshot
Apocynaceae as a Potential Source for Acetylcholinesterase Inhibition in Symptomatic Regulation and Management of Alzheimer's Disease
inferred← citeshttps://doi.org/10.2174/0929867331666230727103553openalex-snapshot
Aducanumab in Alzheimer’s Disease: A Critical Update
inferred← citeshttps://doi.org/10.2174/1381612828666220413094918openalex-snapshot
Neuroproteomics Chip-Based Mass Spectrometry and Other Techniques for Alzheimer’s Disease Biomarkers – Update
inferred← citeshttps://doi.org/10.2174/9789815136142123010004openalex-snapshot
Recent Advances In Tacrine-Based Anti-Alzheimer’s Drug Design
inferred← citeshttps://doi.org/10.2196/30503openalex-snapshot
6G and Artificial Intelligence Technologies for Dementia Care: Literature Review and Practical Analysis
inferred← citeshttps://doi.org/10.31117/neuroscirn.v4i2.81openalex-snapshot
Aducanumab for Alzheimer's disease: An update
inferred← citeshttps://doi.org/10.31393/reports-vnmedical-2026-30(2)-26openalex-snapshot
MULTIFACTORIALITY OF ALZHEIMER’S DISEASE: SCIENTIFIC AND SOCIO-ECONOMIC DIMENSION
inferred← citeshttps://doi.org/10.3233/jad-215026openalex-snapshot
α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3233/jad-215065openalex-snapshot
A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3233/jad-215370openalex-snapshot
JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model1
inferred← citeshttps://doi.org/10.3233/jad-215699openalex-snapshot
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
inferred← citeshttps://doi.org/10.3233/jad-220113openalex-snapshot
Spillover: The Approval of New Medications for Alzheimer’s Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants
inferred← citeshttps://doi.org/10.3233/jad-220666openalex-snapshot
Insights into the Pathophysiology of Alzheimer’s Disease and Potential Therapeutic Targets: A Current Perspective
inferred← citeshttps://doi.org/10.3233/jad-220720openalex-snapshot
Alzheimer’s Disease: A Systems View Provides a Unifying Explanation of Its Development
inferred← citeshttps://doi.org/10.3233/jad-221143openalex-snapshot
Age-Associated UBE2O Reduction Promotes Neuronal Death in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3389/fnagi.2021.720167openalex-snapshot
Ophthalmic Biomarkers for Alzheimer’s Disease: A Review
inferred← citeshttps://doi.org/10.3389/fnagi.2021.733282openalex-snapshot
Editorial: Immunological Mechanisms, Biomarkers and Immunotherapies of Alzheimer's Disease
inferred← citeshttps://doi.org/10.3389/fnagi.2022.949083openalex-snapshot
Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease
inferred← citeshttps://doi.org/10.3389/fnagi.2023.1281748openalex-snapshot
An interpretable Alzheimer’s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification
inferred← citeshttps://doi.org/10.3389/fncel.2022.894601openalex-snapshot
GW5074 Increases Microglial Phagocytic Activities: Potential Therapeutic Direction for Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3389/fneur.2022.948204openalex-snapshot
Retrospective real-world pilot data on transcranial pulse stimulation in mild to severe Alzheimer's patients
inferred← citeshttps://doi.org/10.3389/fnins.2021.752594openalex-snapshot
Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis
inferred← citeshttps://doi.org/10.3389/fnmol.2021.821002openalex-snapshot
Long Non-coding RNA: Insight Into Mechanisms of Alzheimer's Disease
inferred← citeshttps://doi.org/10.3389/fphar.2021.787303openalex-snapshot
Topical Insights Into the Post-Approval Controversies of Aducanumab
inferred← citeshttps://doi.org/10.3389/fpos.2021.747838openalex-snapshot
Integrating Public Participation, Transparency and Accountability Into Governance of Marketing Authorisation for Genome Editing Products
inferred← citeshttps://doi.org/10.3390/bioengineering8120211openalex-snapshot
Alzheimer’s Disease: Current Perspectives and Advances in Physiological Modeling
inferred← citeshttps://doi.org/10.3390/biology12121534openalex-snapshot
Neuroprotective Action of Humanin and Humanin Analogues: Research Findings and Perspectives
inferred← citeshttps://doi.org/10.3390/biom12070996openalex-snapshot
Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/biom14010011openalex-snapshot
The Potential of a Stratified Approach to Drug Repurposing in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/biomedicines10081890openalex-snapshot
Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/biomedicines13020279openalex-snapshot
Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer’s Disease Therapeutics
inferred← citeshttps://doi.org/10.3390/ijms222312987openalex-snapshot
Role of Receptors in Relation to Plaques and Tangles in Alzheimer’s Disease Pathology
inferred← citeshttps://doi.org/10.3390/ijms222313012openalex-snapshot
miRNAs as Therapeutic Tools in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/ijms23158497openalex-snapshot
The Relationship between the Aberrant Long Non-Coding RNA-Mediated Competitive Endogenous RNA Network and Alzheimer’s Disease Pathogenesis
inferred← citeshttps://doi.org/10.3390/ijms24119272openalex-snapshot
Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/ijms241210176openalex-snapshot
A Systematic Review of the Effects of Capsaicin on Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/ijms241310946openalex-snapshot
Phototherapy of Alzheimer’s Disease: Photostimulation of Brain Lymphatics during Sleep: A Systematic Review
inferred← citeshttps://doi.org/10.3390/ijms25105549openalex-snapshot
Parvalbumin Interneuron Dysfunction in Neurological Disorders: Focus on Epilepsy and Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/molecules26216573openalex-snapshot
Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis
inferred← citeshttps://doi.org/10.3390/ph15020174openalex-snapshot
Traditional East Asian Herbal Medicine Treatment for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.3390/ph17060788openalex-snapshot
Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/pharmaceutics16060719openalex-snapshot
Current Progress in Magnetic Resonance-Guided Focused Ultrasound to Facilitate Drug Delivery across the Blood-Brain Barrier
inferred← citeshttps://doi.org/10.3917/cerpsy.135.0010openalex-snapshot
Alzheimer : nouveaux espoirs de traitements
inferred← citeshttps://doi.org/10.47611/jsrhs.v11i3.3301openalex-snapshot
Analyzing the Use of 5XFAD Model Mice in Determining Late-Stage Alzheimer’s Disease Treatment
inferred← citeshttps://doi.org/10.55627/mmc.001.01.0019openalex-snapshot
Alzheimer’s Disease Therapy, and the Effects of Genetic Polymorphisms on Its Efficacy and Safety
inferred← citeshttps://doi.org/10.6084/m9.figshare.15162179openalex-snapshot
Additional file 1 of Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
inferred← citeshttps://doi.org/10.6084/m9.figshare.25322842openalex-snapshot
Additional file 1 of Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer’s disease
inferred← citeshttps://doi.org/10.64628/aap.755kh59p7openalex-snapshot
FDA approval of controversial Alzheimer’s drug could delay discovery of more promising treatments
inferred← citeshttps://doi.org/10.7326/m21-2918openalex-snapshot
U.S. Food and Drug Administration Reasoning in Approval Decisions When Efficacy Evidence Is Borderline, 2013–2018
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.